Fetal Effects of Anticonvulsant Drugs and Seizure Disorders

Schmidt R. P. Wilder B. J. : Epilepsy. F. A. Davis Co., Philadelphia, PA, p. 142, 1968.

Pomerance J. J. Yaffe S. J. : Maternal Medication and its Effects on the Fetus, Curr. Prob. Pediatr. 4: 3–60 (Nov.) 1973.

Desmond M. M. Schwanecke R. P. Wilson G. S. : Maternal Barbiturate Utilization and Neonatal Withdrawal Symptomatology, J. Pediatr. 80: 190–197 (Feb.) 1972.

Schweigert B. F. : Neonatal Hemorrhage Associated with Maternal Use of Diphenylhydantoin, PRN 9 (2): (April) 1976.

Adamansons K. Jolesson I. : The Effects of Pharmacologic Agents Upon the Fetus and Newborn, Am. J. Obstet. Gynecol. 96: 437–460 (Oct.) 1966.

Boreus L. O. : Fetal Pharmacology. Raven Press, New York, 1973.

Cahen B. L. : Evaluation of the Teratogenicity of Drugs, Can. Pharmacol. Ther. 5: 480–514 (July-Aug.) 1964.

Done A. K. : Perinatal Pharmacology, Ann. Rev. Pharmacol. 6: 189–209, 1966.

Eriksson M. Catz C. S. Yaffe S. J. : Drugs and Pregnancy, Clin. Obstet. Gynecol. 16: 199–224 (Mar.) 1973.

Mirkin B. L. : Developmental Pharmacology, Ann. Rev. Pharmacol. 10: 255–272, 1970.

Tuchmann-Duplessis H. : Drug Effects on the Fetus. Adis Press, Sidney, 1975.

Dancis J. Hwang J. : Perinatal Pharmacology. Raven Press, New York, 1974.

Yaffe S. J. : Symposium on Pediatric Pharmacology, Pediatr. Clin. N. Am. 19: (Feb.) 1972.

Yaffe S. J. : Symposium on Drug Therapy in the Neonate, Clin. Perinatology 2: (March) 1975.

Shepard T. H. : Teratogenicity From Drugs—An Increasing Problem, Disease-a-Month: (June) 1974.

Nishimura H. Tanimura T. : Clinical Aspects of the Teratogenicity of Drugs. Am. Elseviar Publishing Co., New York, 1976.

Speidel B. D. Meadow S. R. : Epilepsy, Anticonvulsants and Congenital Malformations, Drugs 8: 345–365, 1974.

Speidel B. D. Meadow S. R. : Maternal Epilepsy and Abnormalities of the Fetus and Newborn, Lancet 2: 839–843 (Oct. 21) 1972.

Annegers J. F. Eluebeck L. R. Hauser W. A. : Do Anticonvulsants Have a Teratogenic Effect? Arch. Neurol. 31: 364–373 (Dec.) 1974.

Janz D. Fuchs V. : Sind Antiepileptische Medikamente Wahrend Der Schwangerschaft Schadlick, Deut Med. Worchenschr. 89: 214–243, 1964.

South J. : Teratogenic Effect of Anticonvulsants, Lancet 2: 1154 (Nov. 25) 1972.

Koppe J. G. : Epilepsie en Aangeboren Afwfkingen, Men. Tijdschr. Geneeskd. 117: 229–234, 1973 (abstracted from reference 21).

Lowe C. R. : Congenital Malformations Among Infants Born to Epileptic Women, Lancet 1: 9–10 (Jan. 6) 1973.

Monson R. R. Rosenberg M. S. Hartz S. C. : Diphenylhydantoin and Selected Congenital Malformations, New Engl. J. Med. 289: 1049–1052 (Nov. 15) 1973.

Shapiro S. Hartz S. C. Siskind V. : Anticonvulsants and Parental Epilepsy in the Development of Birth Defects, Lancet 1: 272–275 (Feb. 7) 1976.

Fedrick J. : Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study, Br. Med. J. 2: 422–448 (May 26) 1973.

Bjerkedal T. Banna S. L. : The Course and Outcome of Pregnancy in Women with Epilepsy, Acta Obstet. Gynecol Scand 52: 245–248, 1973.

MacNaughton M. C. : Maternal Epilepsy and Abnormalities of the Fetus and Newborn, Lancet 2: 1088 (Nov. 18) 1972.

Hill R. B. Verniaud W. M. Horning M. G. : Infants Exposed In Utero to Antiepileptic Drugs. Am. J. Dis. Child 127: 645–653 (May) 1974.

Saxen I. : Associations Between Oral Clefts and Drugs Taken During Pregnancy, Int. J. Epidemiology 4: 37–44 (Jan.) 1975.

Dronamraju K. R. : Epilepsy and Cleft Lip and Palate, Lancet 2: 876–877 (Oct. 24) 1970.

Anticonvulsants in Pregnancy. Drug. Ther. Bull. 13: 33–35 (Apr. 25) 1975.

Mirkin B. L. : Diphenylhydantoin, Placental Transport, Fetal Localization, Neonatal Metabolism and Possible Teratogenic Effects, J. Pediatr. 78: 329–337 (Feb.) 1971.

Melchior J. C. Svensmark O. Trolle D. : Placenta Transfer of Phenobarbitone in Epileptic Women and Elimination in Newborn, Lancet 2: 860–861 (Oct. 21) 1967.

Rane A. : Urinary Excretion of Diphenylhydantoin Metabolites in Newborn Infants, J. Pediatr. 85: 534–545 (Oct.) 1974.

Waddell W. J. Mirkin B. L. : Distribution and Metabolism of Diphenylhydantoin in Fetal and Maternal Tissues of the Pregnant Mouse, Biochem. Pharmacol. 21: 547–552 (Feb. 15) 1972.

Muntz F. Houston E. Schneider R. : Chromosomal Effects of Diphenylhydantoins, Clin. Res. 17: 28 (Jan.) 1969.

Bishun N. P. Smith N. S. Williams D. C. : Chromosomes and Anticonvulsant Drugs. Matation. Res. 28: 141–143, 1975.

Fraser J. L. Watt M. J. : Megaloblastic Anemia in Pregnancy and the Puerperium, Am. J. Obstet. Gynecol. 89: 532–535 (June) 1964.

Hall M. H. : Folic Acid Deficiency and Congenital Malformations, J. Obstet. Gynaecol. Br. Commonw. 79: 159–161, 1972.

Norris J. W. Pratt R. F. : Folic Acid Deficiency and Epilepsy, Drugs 8: 366–385, 1974.

Tyler M. W. King E. Q. : Phenacemide in the treatment of Epilepsy, J. Am. Med. Assoc. 147: 17–21 (Sept. 1) 1951.

Moya F. Thorndike V. : Passage of Drugs Across the Placenta, Am. J. Obstet. Gynecol. 84: 1778–1798 (Dec.) 1962.

Ginsburg J. : Placental Drug Transfer, Ann. Rev. Pharmacol. 2: 387–408, 1971.

Martinez G. Snyder R. D. : Transplacental Passage of Primidone, Neurology 23: 381, 383 (Apr.) 1973.

Forfar J. O. Nelson M. A. : Epidemiology of Drugs Taken By Pregnant Women. Drugs that May Affect the Fetus Adversely, Clin. Pharmacol. Ther. 14: 632–642 (Jul.-Aug.) 1973.

Hill R. M. : Drugs Ingested by Pregnant Women, Clin. Pharmacol. Ther. 14: 654–659 (Jul.-Aug.) 1973.

Seip M. : Growth Retardation, Dysmorphic Facies and Minor Malformations Following Massive Exposure to Phenobarbitone in Utero, Acta Pediatr. Scand. 65: 617–621, 1975.

Hawkins C. F. Meynell M. J. : Macrocytosis and Megaloblastic Anemia in Epileptics on Anticonvulsant Drugs, Q. J. Med. 25: 567–568, 1965.

Hawkins C. F. Meynell M. J. : Macrocytosis and Macrocytic Anemia Caused by Anticonvulsant Drugs, Q. J. Med. 27: 45–63, 1958.

Calvert R. J. Hurworth E. MacBean A. L. : Megaloblastic Anemia from Mephophenobarbital, Blood 13: 894–898 (Sept.) 1958.

Chanarin I. Mollin D. L. Anderson B. B. : Folic Acid Deficiency and the Megaloblastic Anaemias, Proc. R. Soc. Med. 51: 757, 1958.

Manufacturer's product information — Clonazepam, Roche Laboratories Nutley, New Jersey (Aug.) 1975.

Woodbury D. M. Penry J. K. Schmidt R. P. : Antiepileptic Drugs. Raven Press, New York, p. 497, 1972.

Ibid p. 517.

Burt R. A. P. : The Foetal and Maternal Pharmacology of Some of the Drugs Used for the Relief of Pain in Labour, Br. J. Anaesth. 43: 824–836 (Sept.) 1971.

Idanpaan-Heikkila J. E. Jouppila F. T. Poolakka J. O. : Placental Transfer and Fetal Metabolism of Diazepam in Early Human Pregnancy, Am. J. Obstet. Gynecol. 109: 1001–1016 (Apr.) 1971.

Mandelli M. Morselli P. L. Nordio S. : Placental Transfer of Diazepam and its Disposition in the Newborn, J. Clin. Pharmacol. Ther. 17: 564–572 (May) 1975.

Stenchever M. A. Frankel R. B. : Some Effects of Diazepam in Human Cells in Vitro, Am. J. Obstet. Gynecol. 103: 836–842 (Oct.) 1969.

Stenchever M. A. Allen M. : Effect of Diazepam on Chromosomes of Human Leukocytes in Vivo, Am. J. Obstet. Gynecol. 107: 456–460 (July) 1970.

White B. J. Briscoll E. J. Tjio J. : Chromosomal Aberration Rates and Intravenously Given Diazepam, J. Am. Med. Assoc. 230: 414–417 (Oct. 21) 1974.

Istvan E. J. : Drug-Associated Congenital Abnormal-Con. Med Assoc. J. 103: 1394 (Dec. 19) 1970.

Safra M. J. Oakley G. P. : Association Between Cleft Lip with or without Cleft palate and Exposure to Diazepam, Lancet 2: 478–480 (Sept. 13) 1975.

Telephone communication: John J. Pepper, M. D., Director, Department of Medical Services, Roche Laboratories (July) 1972.

Milkovich L. van den Berg B. J. : Effects of Prenatal Meprobamate and Chlordiazepoxide Hydrochloride on Human Embryonic and Fetal Development, New Engl. J. Med. 29: 1268–1271 (Dec. 12) 1974.

Hartz S. C. Heinonen O. P. Shapiro S. : Antenatal Exposure to Meprobamate and Chlordiazepoxide in Relation to Malformations, Mental Development and Childhood Mortality, New Engl. J. Med. 292: 726–728 (Apr. 3) 1975.

Pynnone S. Sallanpoa M. : Carbamazepine and Mothers Milk, Lancet 2: 563 (Sept. 20) 1975.

Product Information—Tegretol®, Geigy Pharmaceuticals (Nov.) 1975.

Hanson J. W. Smith S. W. : The Fetal Hydantoin Syndrome, J. Pediatr. 87: 285–290 (Aug.) 1975.

Barr M. Poznanski A. K. Schmickel R. D. : Digital Hypoplasia and Anticonvulsants During Gestation: A Teratogenic Syndrome? J. Pediatr. 84: 254–256 (Feb.) 1974.

Pendergrass T. W. Hanson J. W. : Fetal Hydantoin Syndrome and Neuroblastoma, Lancet 2: 150 (July) 1976.

Massey K. M. : Teratogenic Effects of Diphenylhydantoin Sodium, J. Oral Ther. 2: 380–385 (Mar.) 1966.

Gibson J. E. Becker B. A. : Teratogenic Effect of Diphenylhydantoin in Swiss-Webster and A/J Mice, Proc. Soc. Exp. Biol. Med. 128: 905–909, 1968.

Elshove J. : Cleft Palate in the Offspring of Female Mice Treated with Phenytoin, Lancet 2: 705, 1969 (abstracted from reference 16).

Harbison R. D. Becker B. A. : Diphenylhydantoin Teratogenicity in Rats, Toxicol. Appl. Pharmacol. 22: 193–200 (June) 1972.

German J. Kowal A. Eklers K. H. : Trimethadione and Human Teratogenesis, Teratology 3: 349–361 (Nov.) 1970.

Nichols M. M. : Fetal Anomalies Following Maternal Trimethadione Ingestion, J. Pediatr. 82: 885–886 (May) 1973.

Rashayan H. Prozansky D. Pruzansky S. : Are Anticonvulsants Teratogenic? Lancet 2: 702–703 (Sept. 25) 1971.

Zellweger H. : Anticonvulsants During Pregnancy: A Danger to the Developing Fetus? Clin. Pediatr. 13: 338–339 (Apr.) 1974.

Zackai E. H. Mellman W. J. Weiderer B. : The Fetal Trimethadione Syndrome, J. Pediatr. 87: 280–284 (Aug.) 1975.

Woodbury D. M. Penry J. K. Schmidt R. P. : Antiepileptic Drugs. Raven Press, New York, p. 422, 1972.

Kienssberg E. V. : Teratogenic Effects of Anticonvulsants. Lancet 1: 198 (Jan. 27) 1973.

Woodbury D. M. Penry J. K. Schmidt R. P. : Antiepileptic Drugs. Raven Press, New York, p. 469, 1972.

Maren T. H. : Teratology and Carbonic Anhydrase Inhibition, Arch. Ophthalmol. 85: 1–2 (Jan.) 1971.

McBride W. G. : The Teratogenic Action of Drugs. Med J. Aust. 2: 689–693 (Oct. 26) 1963.

Horky K. Kuchel O. Gregovrova I. : Effect of Aminoglutethimide on Urinary Steroid Excretion in Patients with Congenital Adrenal Hyperplasia Due to Incomplete 21-hydroxylase Deficiency, Metabolism 21: 305–312, 1972.

Faglia G. Gattinorri L. Travaglini P. : 11-beta-hydroxylase Inhibition During Aminoglutethimide Administration, Metabolism 20: 266–272, 1971.

Hanson T. J. Ballonoff L. B. Northcutt R. C. : Aminoglutethimide and Pregnancy, J. Am. Med. Assoc. 230: 963–964 (Nov. 18) 1974.

Iffy L. Ansell J. Bryant J. : Nonadrenal Female Pseudohermaphroditism: An Unusual Case of Fetal Masculinization, Obstet. Gynecol. 26: 59–65, 1965.

LeMaire W. J. Cleveland W. W. Bejar R. L. : Aminoglutethimide: A possible Cause of Pseudohermaphroditism in Females, Am. J. Dis. Child. 124: 421–423, 1972.

Mangurten H. H. Ban R. : Neonatal Hypotonia Secondary to Transplacental Bromism, J. Pediatr. 85: 426–428 (Sept.) 1974.

Pleasure J. R. Blackburn M. G. : Neonatal Bromide Intoxication: Prenatal Ingestion of a Large Quantity of Bromides with Transplacental Accumulation in the Fetus, Pediatrics 55: 503–506 (Apr.) 1975.

Opitz J. M. Grosse F. R. Haneberg B. : Congenital Effects of Bromism? Lancet 1: 91 (Jan.) 1972.

Rossiter E. J. R. Rendle-Short T. J. : Congenital Effects of Bromism? Lancet 2: 705 (Sept. 30) 1972.